Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04690855
Title A Study to Evaluate TAlazoparib, Radiotherapy and Atezolizumab in gBRCA 1/2 Negative Patients With PD-L1+ Metastatic Triple Negative Breast Cancer (TARA)
Acronym TARA
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Mylin A. Torres, MD
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Alabama at Birmingham Birmingham Alabama 35294 United States Details
Winship Cancer Institute of Emory University Atlanta Georgia 30322 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field